A Guide To Prostate Cancer Clinical Trials
This actionable prostate cancer guide lays out the considerations when managing your diagnosis to help you with the process and to make sure no step is missed along the way.
Prostate cancer occurs when abnormal cells develop within the prostate and is the most common cancer for men in the United States. Most cases progress slowly, with early detection the chances for successful treatment increase. The prostate-specific antigen (PSA) blood test measures the level of protein in the blood made by the prostate and is used to detect any abnormalities within the prostate.
Types of Prostate Cancer include:
- Acinar adenocarcinoma
- Ductal adenocarcinoma
- Transitional cell (or urothelial) cancer
- Squamous cell cancer
- Small cell prostate cancer
Trials Can Help
Around 300 prostate cancer clinical trials are currently active in the United States. These trials are investigating new treatments and detection methods that could save lives in the future such as:
- High-intensity–focused ultrasound therapy
- Proton beam radiation therapy
- Photodynamic therapy
At Massive Bio, our mission is to enable cancer patients to have equal access to cutting-edge therapies and clinical trials, regardless of their location and/or financial stability.
Our Artificial Intelligence (AI) powered Clinical Trial Matching System connects patients and their treating oncologists to clinical trials according to their unique cancer case.
We enlist dedicated staff to collect medical records and treatment history and match patients to eligible trials near their home. We provide full support throughout your enrollment process to ensure logistics are handled so you can concentrate on your health.